FDA Inspection 1120616 - Hemarus, LLC - March 12, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Hemarus, LLC, with an inspection on March 12, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Hemarus, LLC
Inspection Date: March 12, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 34fdf414-920e-4287-90fc-28cd2f2dce5e

Violation Codes3

21 CFR 606.60(a)21 CFR 630.40(b)(3)21 CFR 640.64(e)

Full citation text and observation details available on the Dashboard.